FDA Stock Overview
Designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Fidia S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.046 |
| 52 Week High | €1.15 |
| 52 Week Low | €0.04 |
| Beta | 0.18 |
| 1 Month Change | -10.77% |
| 3 Month Change | -66.98% |
| 1 Year Change | -95.86% |
| 3 Year Change | -97.48% |
| 5 Year Change | -98.80% |
| Change since IPO | -99.66% |
Recent News & Updates
Investors Give Fidia S.p.A. (BIT:FDA) Shares A 34% Hiding
Oct 18
It's Down 40% But Fidia S.p.A. (BIT:FDA) Could Be Riskier Than It Looks
Aug 29Further Upside For Fidia S.p.A. (BIT:FDA) Shares Could Introduce Price Risks After 28% Bounce
Jun 20Recent updates
Investors Give Fidia S.p.A. (BIT:FDA) Shares A 34% Hiding
Oct 18It's Down 40% But Fidia S.p.A. (BIT:FDA) Could Be Riskier Than It Looks
Aug 29Further Upside For Fidia S.p.A. (BIT:FDA) Shares Could Introduce Price Risks After 28% Bounce
Jun 20Estimating The Fair Value Of Fidia S.p.A. (BIT:FDA)
May 28Risks Still Elevated At These Prices As Fidia S.p.A. (BIT:FDA) Shares Dive 31%
Feb 13Is Fidia (BIT:FDA) A Risky Investment?
Dec 23Fidia S.p.A.'s (BIT:FDA) Business Is Trailing The Industry But Its Shares Aren't
Oct 04Shareholder Returns
| FDA | IT Machinery | IT Market | |
|---|---|---|---|
| 7D | -29.9% | -2.6% | -0.9% |
| 1Y | -95.9% | -6.1% | 10.7% |
Return vs Industry: FDA underperformed the Italian Machinery industry which returned -7.3% over the past year.
Return vs Market: FDA underperformed the Italian Market which returned 10.8% over the past year.
Price Volatility
| FDA volatility | |
|---|---|
| FDA Average Weekly Movement | 20.0% |
| Machinery Industry Average Movement | 4.3% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in IT Market | 7.8% |
| 10% least volatile stocks in IT Market | 2.5% |
Stable Share Price: FDA's share price has been volatile over the past 3 months compared to the Italian market.
Volatility Over Time: FDA's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of Italian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | 171 | Luigi Maniglio | www.fidia.it |
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. Its accessories comprise HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; K5 tracer, a solution to perform continuous scanning of 3D surfaces; pushbutton panels; XPower digital drives for axis and spindle movement; and I/O Line input/output modules. The company’s software solutions include ViMill, an anti-collision solution; Machine Monitor, a software to monitor NC variables and parameters; Velocity 6, a solution for axes control to enhance the performances of the machine; HiMill, a CAM software for the machining of dies, models, and aeronautical components; Isograph solution, a user interface; and procedure-PRX, a solution for customized automation.
Fidia S.p.A. Fundamentals Summary
| FDA fundamental statistics | |
|---|---|
| Market cap | €1.44m |
| Earnings (TTM) | -€6.44m |
| Revenue (TTM) | €29.17m |
0.0x
P/S Ratio-0.2x
P/E RatioIs FDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FDA income statement (TTM) | |
|---|---|
| Revenue | €29.17m |
| Cost of Revenue | €10.67m |
| Gross Profit | €18.50m |
| Other Expenses | €24.94m |
| Earnings | -€6.44m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | 63.42% |
| Net Profit Margin | -22.07% |
| Debt/Equity Ratio | 22.3% |
How did FDA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 06:08 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Fidia S.p.A. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jacopo Tagliaferri | Centrobanca SpA |
| Alberto Francese | Intesa Sanpaolo Equity Research |
| Sebastiano Grisetti | Intesa Sanpaolo Equity Research |